ArticleCancer cell2015

Measurement of PIP3 levels reveals an unexpected role for p110β in early adaptive responses to p110α-specific inhibitors in luminal breast cancer.

Carlotta Costa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.